Skip to contentR
Rockwell Medical, Inc.
R
RMTIRockwell Medical, Inc. Q2 2020 · 10-Q
Revenue$15.90M$15.90M+7.1% vs Q2 2019 Net Income-$6.89M-$6.89MN/M vs Q2 2019 EPS Diluted-$0.10-$0.10N/M vs Q2 2019 Gross Profit$881,000+20.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rockwell Medical, Inc. · CIK 1041024 · Engraved from SEC EDGAR
Operating Cash Flowderived-$9,616,000N/M Margins · derivedGross margin5.5%+0.6 pt vs Q2 2019
Operating margin-35.2%+34.6 pt vs Q2 2019
Net margin-43.4%+26.0 pt vs Q2 2019
ended Jun 30, 2020 · filed Aug 10, 2020 · 41 d after period end